4591 - 4600 of 8808 Results
Title
Year
-
OPENTitle: Editorial introductionsJournal Name: Current Opinion in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 35Issue #: 1Start Page: viiEnd Page: ixPublication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wco.0000000000001027Citation Count: 0
- GuiltyTargets: Prioritization of Novel Therapeutic Targets With Network Representation Learning2020OPENTitle: GuiltyTargets: Prioritization of Novel Therapeutic Targets With Network Representation LearningJournal Name: IEEE/ACM Transactions on Computational Biology and BioinformaticsPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 19Issue #: 1Start Page: 491End Page: 500Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/tcbb.2020.3003830Best OA location URL: https://ieeexplore.ieee.org/ielx7/8857/9702518/09121705.pdfCitation Count: 8
-
OPENTitle: ECTRIMS 2022 – PosterJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 28Issue #: 3_supplStart Page: 130End Page: 691Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/13524585221123687Best OA location URL: https://lirias.kuleuven.be/bitstream/20.500.12942/704893/2/poster_ECTRIMS_RIMS_Oct%202022_Peeters.pdfCitation Count: 20
-
RESTRICTEDTitle: Contextual in situ help for visual data interfacesJournal Name: Information VisualizationPublisher: SAGE PublicationsVol: 22Issue #: 1Start Page: 69End Page: 84Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/14738716221120064Citation Count: 7
- Issue Overview2022RESTRICTEDTitle: Issue OverviewJournal Name: ContinuumPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.con.0000840008.09408.75Citation Count: 0
-
OPENTitle: Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy ControlsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903096.36040.1dBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S8.full.pdfCitation Count: 0
-
OPENTitle: A Severe Case of Lupus CerebritisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903100.95793.8aBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S9.full.pdfCitation Count: 1
- Issue Overview2022RESTRICTEDTitle: Issue OverviewJournal Name: ContinuumPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.con.0000892540.33029.c0Citation Count: 0
-
OPENTitle: Protective Association of HLA-DRB1*04 Subtypes in Neurodegenerative Diseases Implicates Acetylated Tau PHF6 SequencesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903160.72715.2dBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S17.1.full.pdfCitation Count: 1
-
OPENTitle: The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor EncephalitisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903316.50895.83Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S39.full.pdfCitation Count: 3